{"tagName":"div","items":[{"tagName":"h2","content":"近一年涨114.5%，上投摩根又拿下一只冠军基！","properties":{"style":{"fontFamily":"-apple-system,BlinkMacSystemFont,\"Helvetica Neue\",\"PingFang SC\",\"Hiragino Sans GB\",\"Microsoft YaHei UI\",\"Microsoft YaHei\",Arial,sans-serif","fontSize":"22px","lineHeight":1.4,"marginBottom":"14px","fontWeight":400}}},{"tagName":"div","content":"div"},{"tagName":"div","items":[{"tagName":"span","content":"上投摩根医药"},{"tagName":"span","content":"上投摩根基金","properties":{"style":{"color":"#d04343","marginLeft":"28px","marginRight":"30px","fontFamily":"112233"}}},{"tagName":"span","content":"2020-07-16","properties":{"style":{"color":"#d5bc44"}}}]},{"tagName":"div","items":[{"data":{"tagName":"img","properties":{"src":"http://localhost:80//upload/img/1625216558537.png","style":{"verticalAlign":"middle","width":"76%"}}},"tagName":"p","properties":{"style":{"display":"flex","justifyContent":"center"}}},{"tagName":"p","content":"2020年上半年全球股市在大幅波动中悄然收官，备受市场关注的QDII基金表现出明显的分化行情，上投摩根中国生物医药基金凭借114.5%的近一年回报夺得银河证券同类冠军。"},{"tagName":"p","content":"上投摩根中国生物医药基金借助稀缺的QDII额度，不受地域限制、A股、港股和美股皆可投，从稀缺性、估值、不同地区股市相关性等多维度选股和构建组合，专注于把握中国生物医药行业的全周期投资机遇。","properties":{"style":{}}},{"tagName":"p","content":"上投摩根中国生物医药基金借助稀缺的QDII额度，不受地域限制、A股、港股和美股皆可投，从稀缺性、估值、不同地区股市相关性等多维度选股和构建组合，专注于把握中国生物医药行业的全周期投资机遇。","properties":{"style":{"color":"rgb(242,102,39)","fontFamily":"-apple-system,BlinkMacSystemFont,\"Helvetica Neue\",\"PingFang SC\",\"Hiragino Sans GB\",\"Microsoft YaHei UI\",\"Microsoft YaHei\",Arial,sans-serif"}}},{"tagName":"p","items":[{"tagName":"span","content":"近几年上投摩根在医药行业的投研上倾注了大量资源并且成效显著，医药投研实力快速崛起，成为医药这个中长期优质赛道上的“种子选手”。银河证券数据显示#，"},{"tagName":"span","content":"截至6月30日，上投摩根中国生物医药基金近一年回报达114.5%，同类排名第一（1/36）；上投摩根医疗健康基金近4年累计回报达170.4%，同类排名第二（2/12）。","properties":{"style":{"color":"rgb(242,102,39)","fontFamily":"-apple-system,BlinkMacSystemFont,\"Helvetica Neue\",\"PingFang SC\",\"Hiragino Sans GB\",\"Microsoft YaHei UI\",\"Microsoft YaHei\",Arial,sans-serif"}}}]},{"data":{"tagName":"img","properties":{"src":"http://localhost:8070/manage/upload/img/2.webp","style":{"verticalAlign":"middle","width":"100%"}}},"tagName":"p"},{"tagName":"p","content":"从过往以及海外的中长期表现来看，医药不失为长期投资的好赛道。"},{"tagName":"p","content":"从长期回报来看，截至6月底，过去20年，A股医疗保健行业累计回报高达756.%，在11个万得一级行业中排名第一；从海外来看，过去50、30、20和10年维度，医疗行业的累计回报均在标普11大行业中排名前四，过去50年、30年更是排名第二。"},{"data":{"tagName":"img","properties":{"src":"http://localhost:8070/manage/upload/img/3.png","style":{"verticalAlign":"middle","width":"100%"}}},"tagName":"p"},{"tagName":"p","content":"△资料来源：万得，数据截至2020.06.30；上图行业分类为万得一级行业。"},{"data":{"tagName":"img","properties":{"src":"http://localhost:8070/manage/upload/img/4.gif","style":{"verticalAlign":"middle","width":"100%"}}},"tagName":"p"}]}],"properties":{"style":{"backgroundColor":"rgba(17,17,17,1)","color":"rgba(255,255,255,0.6)","paddingRight":"22px","fontFamily":"微软雅黑, Arial, sans-serif","paddingBottom":"10px","fontSize":"14px","paddingTop":"7px","paddingLeft":"18px"}}}